CCR2 and prion disease: The expression of the marker of M2-like inflammatory activation, YM1, was in accord with previously reported data (Gomez-Nicola et al., 2013), showing non-significant change with prion disease, and these results were not differentially affected by the WT or CCR2−/− background (Fig. 4D).